Literature DB >> 11437800

Global measures of impairment in children and adolescents: results from a Swiss community survey.

H C Steinhausen1, C W Metzke.   

Abstract

OBJECTIVE: Based on data from a Swiss epidemiological survey, both the parent and the child versions of two global measures of impairment, the Columbia Impairment Scale (CIS) and the Children's Global Assessment Scale (CGAS) were analysed with regard to validity and the effects of gender.
METHOD: Concurrent and discriminant validity were evaluated by examining the associations with other indicators of impairment. Gender effects on impairment were considered in each type of analysis.
RESULTS: Based on the total sample and on the girls' data, concurrent validity of the various impairment scores as computed by correlations with other indicators of psychological dysfunction was good. When based on the boys' data it was less convincing. Discriminant validity was estimated by comparing impairment scores between those using and not using services and was proven for all impairment scores. There were significant gender effects for almost all scores, indicating that girls in contrast to boys were more impaired and functioned less well when professional contacts and psychiatric diagnosis were considered.
CONCLUSIONS: The two impairment measures are well suited to community studies. Gender and informant differences have to be considered when defining thresholds for caseness. The two scales could also be used clinically, for example for training and evaluation purposes and for the decision whether or not a child or adolescent requires treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11437800     DOI: 10.1046/j.1440-1614.2001.00901.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

1.  Which factors impact on clinician-rated impairment in children with ADHD?

Authors:  David Coghill; Georg Spiel; Gisli Baldursson; Manfred Döpfner; Maria J Lorenzo; Stephen J Ralston; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

2.  Characteristics and anxiety symptom presentation associated with autism spectrum traits in youth with anxiety disorders.

Authors:  Cara A Settipani; Connor M Puleo; Bradley T Conner; Philip C Kendall
Journal:  J Anxiety Disord       Date:  2012-02-07

3.  Adult household smoking is associated with increased child emotional and behavioral problems.

Authors:  Elizabeth Poole-Di Salvo; Ying-Hua Liu; Samantha Brenner; Michael Weitzman
Journal:  J Dev Behav Pediatr       Date:  2010 Feb-Mar       Impact factor: 2.225

4.  Deficits in attention to emotional stimuli distinguish youth with severe mood dysregulation from youth with bipolar disorder.

Authors:  Brendan A Rich; Melissa A Brotman; Daniel P Dickstein; Derek G V Mitchell; R James R Blair; Ellen Leibenluft
Journal:  J Abnorm Child Psychol       Date:  2010-07

Review 5.  Global assessment of psychosocial functioning in child and adolescent psychiatry. A review of three unidimensional scales (CGAS, GAF, GAPD).

Authors:  Bjørg Elisabeth Haugen Schorre; Inger Helene Vandvik
Journal:  Eur Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 4.785

6.  Adverse Prenatal, Perinatal and Neonatal Experiences in Children with Anxiety Disorders.

Authors:  Carly Johnco; Adam B Lewin; Alison Salloum; Tanya K Murphy; Erika A Crawford; Brittney F Dane; Nicole M McBride; Eric A Storch
Journal:  Child Psychiatry Hum Dev       Date:  2016-04

7.  Healthcare expenditures for autism during times of school transition: some vulnerable families fall behind.

Authors:  Kathleen C Thomas; Susan L Parish; Christianna S Williams
Journal:  Matern Child Health J       Date:  2014-10

8.  Childhood Symptoms of ADHD Overrule Comorbidity in Relation to Psychosocial Outcome at Age 15: A Longitudinal Study.

Authors:  Eva Norén Selinus; Yasmina Molero; Paul Lichtenstein; Tomas Larson; Sebastian Lundström; Henrik Anckarsäter; Clara Hellner Gumpert
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.